{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:11:34Z","timestamp":1777349494043,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["308913"],"award-info":[{"award-number":["308913"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HUS Diagnostic Center"},{"name":"University of Helsinki including Helsinki University Central Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Lymphocyte responses to mitogens constitute a key part of the diagnostics of combined immunodeficiency (CID). Currently, mostly radioactive thymidine incorporation and carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution methods are used. Flow-cytometric assay for specific cell-mediated immune-response in activated whole blood (FASCIA) has been put forth as an easy-to-perform option for the measurement of lymphocyte responses with the advantage of recognizing different lymphocyte subtypes and avoiding the use of radioactive reagents. Our aim was to analyze retrospectively the usefulness of FASCIA in the diagnostics of CID. We included all lymphocyte stimulation tests done with FASCIA in HUSLAB (Helsinki, Finland) between February 2015 and September 2018 in our analysis. The cohort was divided into two groups according to the patients\u2019 final diagnoses: CID (<jats:italic>n<\/jats:italic>\u2009=\u200930) or non-CID (<jats:italic>n<\/jats:italic>\u2009=\u2009159). We evaluated the stimulation responses with a combined FASCIA score (the average of all mitogen responses). The FASCIA score was significantly lower among the CID group compared to the other patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), and in the ROC analysis, the AUC was 0.75 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) for the FASCIA score. When the three mitogens were analyzed separately, phytohemagglutinin (PHA) was best in separating patients with CID from non-CID (in the ROC analysis AUC 0.71, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). Immunosuppressive medication affected the FASCIA result significantly and needs to be considered when evaluating the results. In conclusion, FASCIA can reliably detect the CID patients in the absence of immunosuppressive medication. It emerges as a method with many benefits compared to tests requiring radioactive reagents or the complicated CFSE staining.<\/jats:p>","DOI":"10.1007\/s10875-022-01417-z","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T12:04:07Z","timestamp":1670933047000},"page":"653-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FASCIA Method in the Assessment of Lymphocyte Mitogen Responses in the Laboratory Diagnostics of Primary Immunodeficiencies"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-7070","authenticated-orcid":false,"given":"Pauliina","family":"Lusila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-354X","authenticated-orcid":false,"given":"Hanna","family":"Jarva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-0135","authenticated-orcid":false,"given":"Kim","family":"Vettenranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6045-108X","authenticated-orcid":false,"given":"Eliisa","family":"Kek\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"issue":"1","key":"1417_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24\u201364. https:\/\/doi.org\/10.1007\/s10875-019-00737-x.","journal-title":"J Clin Immunol"},{"issue":"6","key":"1417_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763\u201370. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.004.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1417_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.iac.2015.07.002","volume":"35","author":"IK Chinn","year":"2015","unstructured":"Chinn IK, Shearer WT. Severe combined immunodeficiency disorders. Immunol Allergy Clin North Am. 2015;35(4):671\u201394. https:\/\/doi.org\/10.1016\/j.iac.2015.07.002.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"1417_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2008.11.003","volume":"131","author":"KD Stone","year":"2009","unstructured":"Stone KD, Feldman HA, Huisman C, Howlett C, Jabara HH, Bonilla FA. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency. Clin Immunol. 2009;131(1):41\u20139. https:\/\/doi.org\/10.1016\/j.clim.2008.11.003.","journal-title":"Clin Immunol"},{"issue":"12","key":"1417_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/cyto.a.22403","volume":"83","author":"J Begum","year":"2013","unstructured":"Begum J, Day W, Henderson C, Purewal S, Cerveira J, Summers H, et al. A method for evaluating the use of fluorescent dyes to track proliferation in cell lines by dye dilution. Cytometry A. 2013;83(12):1085\u201395. https:\/\/doi.org\/10.1002\/cyto.a.22403.","journal-title":"Cytometry A"},{"issue":"1\u20132","key":"1417_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cellimm.2009.01.007","volume":"256","author":"J Last\u2019ovicka","year":"2009","unstructured":"Last\u2019ovicka J, Budinsk\u00fd V, Sp\u00edsek R, Bartunkov\u00e1 J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cell Immunol. 2009;256(1\u20132):79\u201385. https:\/\/doi.org\/10.1016\/j.cellimm.2009.01.007.","journal-title":"Cell Immunol."},{"issue":"12","key":"1417_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.humimm.2016.08.012","volume":"77","author":"J Last\u2019ovicka","year":"2016","unstructured":"Last\u2019ovicka J, Rataj M, Bartunkov\u00e1 J. Assessment of lymphocyte proliferation for diagnostic purpose: comparison of CFSE staining Ki-67 expression and 3H-thymidine incorporation. Hum Immunol. 2016;77(12):1215\u201322. https:\/\/doi.org\/10.1016\/j.humimm.2016.08.012.","journal-title":"Hum Immunol."},{"issue":"2","key":"1417_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clim.2014.05.010","volume":"153","author":"P Marits","year":"2014","unstructured":"Marits P, Wikstr\u00f6m A-C, Popadic D, Winqvist O, Thunberg S. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. Clin Immunol. 2014;153(2):332\u201342. https:\/\/doi.org\/10.1016\/j.clim.2014.05.010.","journal-title":"Clin Immunol"},{"issue":"8","key":"1417_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/cyto.a.21096","volume":"79","author":"RM B\u00f6hmer","year":"2011","unstructured":"B\u00f6hmer RM, Bandala-Sanchez E, Harrison LC. Forward light scatter is a simple measure of T-cell activation and proliferation but is not universally suited for doublet discrimination. Cytometry A. 2011;79(8):646\u201352. https:\/\/doi.org\/10.1002\/cyto.a.21096.","journal-title":"Cytometry A"},{"key":"1417_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2307\/3001634","volume":"9","author":"WJ Dixon","year":"1953","unstructured":"Dixon WJ. Processing data for outliers. Biometrics. 1953;9:74\u201389.","journal-title":"Biometrics"},{"issue":"9","key":"1417_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315\u20136. https:\/\/doi.org\/10.1097\/JTO.0b013e3181ec173d.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1417_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2012.04.029","volume":"130","author":"CM Roifman","year":"2012","unstructured":"Roifman CM, Somech R, Kavadas F, Pires L, Nahum A, Dalal I, et al. Defining combined immunodeficiency. J Allergy Clin Immunol. 2012;130(1):177\u201383. https:\/\/doi.org\/10.1016\/j.jaci.2012.04.029.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1417_CR13","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3389\/fimmu.2018.02367","volume":"16","author":"C Albert-Vega","year":"2018","unstructured":"Albert-Vega C, Tawfik DM, Trouillet-Assant S, Vachot L, Mallet F, Textoris J. Immune functional assays, from custom to standardized tests for precision medicine. Front Immunol. 2018;16(9):2367. https:\/\/doi.org\/10.3389\/fimmu.2018.02367.","journal-title":"Front Immunol"},{"issue":"2","key":"1417_CR14","first-page":"440","volume":"70","author":"DM Murasko","year":"1987","unstructured":"Murasko DM, Weiner P, Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol. 1987;70(2):440\u20138.","journal-title":"Clin Exp Immunol"},{"key":"1417_CR15","doi-asserted-by":"publisher","first-page":"113159","DOI":"10.1016\/j.jim.2021.113159","volume":"499","author":"S Lind Enoksson","year":"2021","unstructured":"Lind Enoksson S, Bergman P, Klingstr\u00f6m J, Bostr\u00f6m F, Da Silva RR, Winerdal ME, Marits P. A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2. J Immunol Methods. 2021;499:113159. https:\/\/doi.org\/10.1016\/j.jim.2021.113159.","journal-title":"J Immunol Methods"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01417-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01417-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T08:24:52Z","timestamp":1677227092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01417-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1417"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01417-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Administration of Helsinki University Hospital (HUS\/157\/2020). Since this was a retrospective registry study with no patient intervention, ethics committee approval and informed consent were not required by Finnish national legislation in accordance with the Medical Research Act of Finland 488\/1999.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}